Marx Biotechnology is dedicated to providing novel diagnostic and therapeutic solutions. Using an innovative platform technology, we are developing diagnostic kits for a variety of diseases and our current focus is the early detection of Graft-versus-Host-Disease (GVHD). Our diagnostic kit for GVHD will provide a faster and more reliable tool than anything currently on the market.
We have successfully completed proof of concept studies in an animal model. The data was given over in a poster presentation at the 24thInternational Congress of the Transplantation Society and will be published in the June edition of the peer review journal Transplantation Proceedings.